Can Hu
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
Papers in
-
- Gastric Cancer Management and Outcomes 23
- Ferroptosis and cancer prognosis 6
- Oncology 23
- Cancer Immunotherapy and Biomarkers 6
- Cancer Cells and Metastasis 4
- Co-authors
- Xiangdong Cheng (25 shared papers)Yuan Li (20 shared papers)Jiang‐Jiang Qin (10 shared papers)Zhiyuan Xu (29 shared papers)Jinyun Dong (4 shared papers)Yanqiang Zhang (26 shared papers)Xiangdong Cheng (17 shared papers)Zhiyuan Xu (11 shared papers)
- Journals
- Annals of Translational Medicine (3 papers)Journal of Oncology (3 papers)Frontiers in Oncology (3 papers)Cancer Biology and Medicine (3 papers)Neurocomputing (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Can Hu
102 papers receiving 2.0k citations
Can Hu's Hit Papers
Peers
Comparison fields: 5 of 138
- Oncology 460
- Cancer Research 246
- Pulmonary and Respiratory Medicine 374
- Immunology 200
- Molecular Biology 623
Countries citing papers authored by Can Hu
This map shows the geographic impact of Can Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Can Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Can Hu more than expected).
Fields of papers citing papers by Can Hu
This network shows the impact of papers produced by Can Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Can Hu. The network helps show where Can Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Can Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 110 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance Hit paper breakdown → | 2023 | 298 |
| 2 | 2023 | 129 | |
| 3 | The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors Hit paper breakdown → | 2024 | 118 |
| 4 | 2023 | 113 | |
| 5 | Development of a tongue image-based machine learning tool for the diagnosis of gastric cancer: a prospective multicentre clinical cohort study Hit paper breakdown → | 2023 | 96 |
| 6 | 2023 | 65 | |
| 7 | 2023 | 59 | |
| 8 | 2024 | 52 | |
| 9 | 2020 | 49 | |
| 10 | 2021 | 48 | |
| 11 | 2023 | 46 | |
| 12 | 2024 | 38 | |
| 13 | 2016 | 35 | |
| 14 | 2018 | 35 | |
| 15 | 2024 | 34 | |
| 16 | 2019 | 33 | |
| 17 | 2023 | 31 | |
| 18 | 2023 | 30 | |
| 19 | 2023 | 30 | |
| 20 | eIF5A2 regulates the resistance of gastric cancer cells to cisplatin via induction of EMT. | 2018 | 30 |
About Can Hu
Can Hu is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Aging and Pathology and Forensic Medicine, having authored 110 papers that have together received 2.0k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (23 papers), Cancer Mechanisms and Therapy (7 papers), Ferroptosis and cancer prognosis (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Radiomics and Machine Learning in Medical Imaging (6 papers), Genetics, Aging, and Longevity in Model Organisms (5 papers), Cancer Cells and Metastasis (4 papers) and Immune Cell Function and Interaction (4 papers). The work is most often cited by research in Oncology (460 citations), Cancer Research (246 citations), Pulmonary and Respiratory Medicine (374 citations), Immunology (200 citations) and Molecular Biology (623 citations). Can Hu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Xiangdong Cheng, Yuan Li, Jiang‐Jiang Qin, Zhiyuan Xu, Jinyun Dong, Yanqiang Zhang, Xiangdong Cheng, Zhiyuan Xu, Hang Lv and Xiang Liu. Their work appears in journals such as Annals of Translational Medicine, Journal of Oncology, Frontiers in Oncology, Cancer Biology and Medicine and Neurocomputing.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.